0001493152-21-004623.txt : 20210223
0001493152-21-004623.hdr.sgml : 20210223
20210223172115
ACCESSION NUMBER: 0001493152-21-004623
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200718
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glynn Craig
CENTRAL INDEX KEY: 0001809590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38325
FILM NUMBER: 21666864
MAIL ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hancock Jaffe Laboratories, Inc.
CENTRAL INDEX KEY: 0001661053
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330936180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-261-2900
MAIL ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
ownership.xml
X0306
4
2020-07-18
0
0001661053
Hancock Jaffe Laboratories, Inc.
HJLI
0001809590
Glynn Craig
C/O JAFFE LABORATORIES,
70 DOPPLER
IRVINE
CA
92618
0
1
0
0
Chief Financial Officer
Stock Option
10.00
2020-07-18
4
A
0
4000
0
A
2030-07-18
Common Stock
4000
4000
D
Stock Option
8.20
2021-02-18
4
A
0
324000
0
A
2031-02-18
Common Stock
324.000
324.000
D
The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan").
The stock option vests in equal quarterly installments over a three year period commencing October 18, 2020.
The stock options vest in equal quarterly installments over a three year period, however the stock options may only become exercisable following receipt by the registrant of stockholder approval to increase the size of the Plan sufficiently to permit the exercise in full of such stock options under the Plan. If the registrant's stockholders do not approve an increase in the size of the Plan, the options will be void.
/s/ Craig Glynn
2021-02-23